难治性心绞痛的治疗
Treatment of refractory angina.
作者信息
Grise Mark A, Verma Anil
机构信息
Department of Cardiology, Ochsner Clinic Foundation, New Orleans, LA.
出版信息
Ochsner J. 2009 Winter;9(4):220-6.
Abstract
It is estimated that as many as 1,000,000 people in the United States have chronic symptomatic coronary artery disease (often referred to as refractory angina) that is recalcitrant to medical therapy and unamenable to conventional revascularization procedures. Patients have reproducible lifestyle-limiting symptoms of chest pain, shortness of breath, and easy fatigability. Several new therapies are available to treat this difficult patient population, including newer drugs, enhanced external counterpulsation, transmyocardial revascularization, and cell-based therapies. This article reviews the current state of the art for treatment of refractory angina.
摘要
据估计，美国多达100万人患有慢性症状性冠状动脉疾病（常被称为顽固性心绞痛），这种疾病对药物治疗无效且无法进行传统的血运重建手术。患者有可重现的限制生活方式的胸痛、呼吸急促和易疲劳症状。有几种新的疗法可用于治疗这一难治性患者群体，包括新型药物、增强型体外反搏、经心肌血运重建和基于细胞的疗法。本文综述了顽固性心绞痛治疗的当前技术水平。
相似文献
1
Treatment of refractory angina.难治性心绞痛的治疗
Ochsner J. 2009 Winter;9(4):220-6.
2
Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.增强型体外反搏（EECP）：基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(5):1-70. Epub 2006 Mar 1.
3
Alternative therapy for medically refractory angina: enhanced external counterpulsation and transmyocardial laser revascularization.难治性心绞痛的替代疗法：增强型体外反搏和经皮激光心肌血运重建术。
Cardiol Clin. 2014 Aug;32(3):429-38. doi: 10.1016/j.ccl.2014.04.009.
4
Alternative Therapy for Medically Refractory Angina: Enhanced External Counterpulsation and Transmyocardial Laser Revascularization.
Heart Fail Clin. 2016 Jan;12(1):107-16. doi: 10.1016/j.hfc.2015.08.009.
5
Treatment of inoperable coronary disease and refractory angina: spinal stimulators, epidurals, gene therapy, transmyocardial laser, and counterpulsation.不可手术的冠心病和难治性心绞痛的治疗：脊髓刺激器、硬膜外治疗、基因治疗、经心肌激光打孔术和反搏术。
Semin Cardiothorac Vasc Anesth. 2004 Mar;8(1):43-58. doi: 10.1177/108925320400800109.
6
Emerging therapies for refractory angina.
Minn Med. 2008 Jan;91(1):36-9.
7
Refractory Angina: the Current State of Mechanical Therapies.难治性心绞痛：机械治疗的现状。
Curr Cardiol Rep. 2019 Apr 22;21(6):46. doi: 10.1007/s11886-019-1134-8.
8
Treatment of refractory angina pectoris.难治性心绞痛的治疗。
Int J Cardiol. 2005 May 11;101(1):1-7. doi: 10.1016/j.ijcard.2004.03.066.
9
The effectiveness of enhanced external counterpulsation (EECP) in patients suffering from chronic refractory angina previously treated with transmyocardial laser revascularisation.增强型体外反搏（EECP）对先前接受过心肌激光血运重建术治疗的慢性顽固性心绞痛患者的疗效。
Int J Cardiol. 2013 Oct 9;168(4):4383-5. doi: 10.1016/j.ijcard.2013.05.050. Epub 2013 May 25.
10
Angina and Its Management.心绞痛及其治疗
J Cardiovasc Pharmacol Ther. 2017 May;22(3):199-209. doi: 10.1177/1074248416679733. Epub 2016 Dec 14.
本文引用的文献
1
Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial.心肌内注射骨髓细胞治疗慢性心肌缺血：一项随机对照试验。
JAMA. 2009 May 20;301(19):1997-2004. doi: 10.1001/jama.2009.685.
2
Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.If电流抑制剂伊伐布雷定在接受β受体阻滞剂治疗的慢性稳定型心绞痛患者中的疗效：一项为期4个月的随机安慰剂对照试验。
Eur Heart J. 2009 Mar;30(5):540-8. doi: 10.1093/eurheartj/ehn571. Epub 2009 Jan 9.
3
Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial).骨髓细胞直接心内膜下植入治疗严重冠状动脉疾病的前瞻性随机试验（PROTECT-CAD试验）。
Eur Heart J. 2007 Dec;28(24):2998-3005. doi: 10.1093/eurheartj/ehm485. Epub 2007 Nov 5.
4
Enhanced external counterpulsation and future directions: step beyond medical management for patients with angina and heart failure.增强型体外反搏及未来发展方向：超越心绞痛和心力衰竭患者的药物治疗。
J Am Coll Cardiol. 2007 Oct 16;50(16):1523-31. doi: 10.1016/j.jacc.2007.07.024. Epub 2007 Oct 1.
5
Statin wars: emphasis on potency vs event reduction and safety?他汀类药物之争：重点在于效力、事件减少还是安全性？
Mayo Clin Proc. 2007 May;82(5):539-42. doi: 10.4065/82.5.539.
6
Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.雷诺嗪对非ST段抬高型急性冠状动脉综合征患者心血管事件复发的影响：MERLIN-TIMI 36随机试验
JAMA. 2007 Apr 25;297(16):1775-83. doi: 10.1001/jama.297.16.1775.
7
Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine.抑制晚钠电流作为一种潜在的心脏保护机制：晚钠电流抑制剂雷诺嗪的作用
Heart. 2006 Jul;92 Suppl 4(Suppl 4):iv6-iv14. doi: 10.1136/hrt.2005.078790.
8
Funny channels in the control of cardiac rhythm and mode of action of selective blockers.心脏节律控制中的“有趣通道”及选择性阻滞剂的作用方式
Pharmacol Res. 2006 May;53(5):399-406. doi: 10.1016/j.phrs.2006.03.006. Epub 2006 Mar 27.
9
10
Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease.晚期心脏病患者经心内膜自体骨髓细胞移植的安全性与可行性
Am J Cardiol. 2006 Mar 15;97(6):823-9. doi: 10.1016/j.amjcard.2005.09.132. Epub 2006 Jan 30.
Zotero 插件